The immunological impact of the RAF inhibitor BMS908662: Preclinical and early clinical experience in combination with CTLA-4 blockade.
暂无分享,去创建一个
J. Wolchok | M. Callahan | J. Wigginton | A. Gupta | T. Merghoub | M. Jure-Kunkel | Jianda Yuan | G. Masters | J. Katz | R. Roman | M. Montefusco | S. Vyas | Valerie Russell